Bank of America’s Guardant Health GH Stock Holding History

Bank of America’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-800	Closed	-$50K	–	7738
2025 Q3	$50K	Buy	+800	New	+$43.5K	﹤0.01%	6834
2024 Q2	–	Sell	-75,000	Closed	-$1.55M	–	8290
2024 Q1	$1.55M	Buy	+75,000	New	+$1.61M	﹤0.01%	4624
2022 Q4	–	Sell	-400	Closed	-$22K	–	8292
2022 Q3	$22K	Buy	+400	New	+$20.5K	﹤0.01%	6992
2022 Q1	–	Sell	-26,400	Closed	-$2.64M	–	8437
2021 Q4	$2.64M	Buy	+26,400	New	+$2.73M	﹤0.01%	4284
2021 Q2	–	Sell	-45,300	Closed	-$6.92M	–	7860
2021 Q1	$6.92M	Buy	+45,300	New	+$6.85M	﹤0.01%	3069

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America's GH Position: Q1 2026 in Review

Bank of America reduced its Guardant Health (GH) stake by 12% in Q1 2026, selling an estimated $12.3M and leaving 895,221 shares worth $82.7M. The position accounts for 0.01% of the portfolio, ranked #1261.

Bank of America first reported a position in GH in Q4 2018 and has held it in 30 quarters since. The position peaked at $162M in Q1 2021. 483 funds tracked by Wall St. Rank hold GH as of Q1 2026.

Bank of America held 895,221 shares of Guardant Health worth $82.7M as of Q1 2026.
Bank of America sold 122,425 Guardant Health shares in Q1 2026, an estimated $12.3M.
Guardant Health made up 0.01% of Bank of America's portfolio in Q1 2026, its #1261 holding.
Bank of America first reported a position in Guardant Health in Q4 2018 and has held it in 30 quarters since.
Bank of America's Guardant Health position peaked at $162M in Q1 2021.
483 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.